GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (STU:63N) » Definitions » Days Sales Outstanding

BIMI International Medical (STU:63N) Days Sales Outstanding : 188.10 (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is BIMI International Medical Days Sales Outstanding?

BIMI International Medical's average Accounts Receivable for the three months ended in Sep. 2023 was €4.87 Mil. BIMI International Medical's Revenue for the three months ended in Sep. 2023 was €2.36 Mil. Hence, BIMI International Medical's Days Sales Outstanding for the three months ended in Sep. 2023 was 188.10.

The historical rank and industry rank for BIMI International Medical's Days Sales Outstanding or its related term are showing as below:

STU:63N' s Days Sales Outstanding Range Over the Past 10 Years
Min: 107.53   Med: 315.87   Max: 433.19
Current: 142.8

During the past 13 years, BIMI International Medical's highest Days Sales Outstanding was 433.19. The lowest was 107.53. And the median was 315.87.

STU:63N's Days Sales Outstanding is ranked worse than
91.56% of 640 companies
in the Healthcare Providers & Services industry
Industry Median: 45.94 vs STU:63N: 142.80

BIMI International Medical's Days Sales Outstanding increased from Sep. 2022 (117.14) to Sep. 2023 (188.10).


BIMI International Medical Days Sales Outstanding Historical Data

The historical data trend for BIMI International Medical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Days Sales Outstanding Chart

BIMI International Medical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 190.02 103.46 134.44

BIMI International Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.14 363.86 102.11 84.90 188.10

Competitive Comparison of BIMI International Medical's Days Sales Outstanding

For the Pharmaceutical Retailers subindustry, BIMI International Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI International Medical's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's Days Sales Outstanding falls into.



BIMI International Medical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BIMI International Medical's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (5.199 + 3.028) / 2 ) / 11.168*365
=4.1135 / 11.168*365
=134.44

BIMI International Medical's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (5.889 + 3.857) / 2 ) / 2.364*365 / 4
=4.873 / 2.364*365 / 4
=188.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIMI International Medical  (STU:63N) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


BIMI International Medical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI International Medical (STU:63N) Business Description

Traded in Other Exchanges
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI International Medical (STU:63N) Headlines

No Headlines